Osaka, Japan

Kazuhiko Senokuchi

This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiko Senokuchi. Retrieved from https://idiyas.com/inventor/kazuhiko-senokuchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuhiko Senokuchi: Innovator in Pharmaceutical Chemistry

Introduction

Kazuhiko Senokuchi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on amidino derivatives.

Latest Patents

Senokuchi holds a patent for "Amidino derivatives and drugs containing the same as the active ingredient." This patent showcases his expertise in developing new compounds that have potential therapeutic applications.

Career Highlights

Kazuhiko Senokuchi is associated with Ono Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work at Ono has allowed him to focus on research and development, contributing to advancements in drug formulation and efficacy.

Collaborations

Senokuchi has collaborated with Koji Ogawa, enhancing the research efforts within their team. Their combined expertise has led to innovative solutions in drug development.

Conclusion

Kazuhiko Senokuchi's contributions to pharmaceutical chemistry through his patent and collaboration with colleagues highlight his role as an influential inventor in the industry. His work continues to pave the way for future innovations in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…